-+ 0.00%
-+ 0.00%
-+ 0.00%

Tyra Biosciences Q4 2024 GAAP EPS $(0.43) Beats $(0.47) Estimate

Benzinga·03/27/2025 20:19:42
Listen to the news
Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.47) by 8.51 percent. This is a 18.87 percent increase over losses of $(0.53) per share from the same period last year.